Royalty Pharma To Debut On Nasdaq On June 16

Royalty Pharma is an acquirer of revenue-producing intellectual property - principally royalty interests in marketed and late stage biopharmaceutical products.

from RTT - Biotech https://ift.tt/3ftIZt1
via IFTTT